Severe Congenital Diaphragmatic Hernia (CDH)

A critical analysis of eight years' experience

Pietro Bagolan, G. Casaccia, A. Nahom, A. Trucchi, A. Zangari, R. Laviani, N. Pirozzi, G. Di Liso, M. Orzalesi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objectives: 1) To define the best outcome of severe Congenital Diaphragmatic Hernia (CDH); 2) to critically evaluate deaths in order to identify possible criteria of exclusion from ECMO; and 3) to identify CDHs which could benefit from ECMO. Materials and Methods: 63 severe CDHs, 35 (55.6%) survivors and 28 (44.4%) nonsurvivors, subdivided into 2 groups according to age at death: Group I dying at 12 ≤ 24 hours, and Group II dying at > 24 hours after birth. The three groups were compared on the basis of prenatal diagnosis, polyhydramnios, gestational age, birth weight, pneumothorax, best values of postductal PaCO2 and PaO2, clinical and echocardiographic signs of persistent pulmonary hypertension, and severity of pulmonary hypoplasia (i.e., body weight to bilateral lung weight ratio at autopsy). Results: PaCO2, PaO2 and degree of pulmonary hypoplasia were significantly worse in Group I compared to Group II and to survivors. PaCO2 and PaO2 in Group II did not differ significantly from those of survivors. Conclusions: In severe CDH it is possible: 1) to achieve a survival rate of 56% without ECMO; 2) to identify a group of patients (Group 1 = 27%) with severe pulmonary hypoplasia who would probably die even with ECMO; and 3) to identify a group of patients (Group II = 17%) who might benefit from ECMO treatment.

Original languageEnglish
Pages (from-to)95-100
Number of pages6
JournalEuropean Journal of Pediatric Surgery
Volume12
Issue number2
DOIs
Publication statusPublished - 2002

Fingerprint

Survivors
Lung
Polyhydramnios
Extracorporeal Membrane Oxygenation
Pneumothorax
Prenatal Diagnosis
Pulmonary Hypertension
Birth Weight
Gestational Age
Autopsy
Survival Rate
Body Weight
Parturition
Weights and Measures
Congenital Diaphragmatic Hernias

Keywords

  • Congenital diaphragmatic hernia
  • ECMO
  • Pulmonary hypoplasia prediction

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Severe Congenital Diaphragmatic Hernia (CDH) : A critical analysis of eight years' experience. / Bagolan, Pietro; Casaccia, G.; Nahom, A.; Trucchi, A.; Zangari, A.; Laviani, R.; Pirozzi, N.; Di Liso, G.; Orzalesi, M.

In: European Journal of Pediatric Surgery, Vol. 12, No. 2, 2002, p. 95-100.

Research output: Contribution to journalArticle

Bagolan, Pietro ; Casaccia, G. ; Nahom, A. ; Trucchi, A. ; Zangari, A. ; Laviani, R. ; Pirozzi, N. ; Di Liso, G. ; Orzalesi, M. / Severe Congenital Diaphragmatic Hernia (CDH) : A critical analysis of eight years' experience. In: European Journal of Pediatric Surgery. 2002 ; Vol. 12, No. 2. pp. 95-100.
@article{d0f83df9380e4ea49a7895e0b39ee980,
title = "Severe Congenital Diaphragmatic Hernia (CDH): A critical analysis of eight years' experience",
abstract = "Objectives: 1) To define the best outcome of severe Congenital Diaphragmatic Hernia (CDH); 2) to critically evaluate deaths in order to identify possible criteria of exclusion from ECMO; and 3) to identify CDHs which could benefit from ECMO. Materials and Methods: 63 severe CDHs, 35 (55.6{\%}) survivors and 28 (44.4{\%}) nonsurvivors, subdivided into 2 groups according to age at death: Group I dying at 12 ≤ 24 hours, and Group II dying at > 24 hours after birth. The three groups were compared on the basis of prenatal diagnosis, polyhydramnios, gestational age, birth weight, pneumothorax, best values of postductal PaCO2 and PaO2, clinical and echocardiographic signs of persistent pulmonary hypertension, and severity of pulmonary hypoplasia (i.e., body weight to bilateral lung weight ratio at autopsy). Results: PaCO2, PaO2 and degree of pulmonary hypoplasia were significantly worse in Group I compared to Group II and to survivors. PaCO2 and PaO2 in Group II did not differ significantly from those of survivors. Conclusions: In severe CDH it is possible: 1) to achieve a survival rate of 56{\%} without ECMO; 2) to identify a group of patients (Group 1 = 27{\%}) with severe pulmonary hypoplasia who would probably die even with ECMO; and 3) to identify a group of patients (Group II = 17{\%}) who might benefit from ECMO treatment.",
keywords = "Congenital diaphragmatic hernia, ECMO, Pulmonary hypoplasia prediction",
author = "Pietro Bagolan and G. Casaccia and A. Nahom and A. Trucchi and A. Zangari and R. Laviani and N. Pirozzi and {Di Liso}, G. and M. Orzalesi",
year = "2002",
doi = "10.1055/s-2002-30159",
language = "English",
volume = "12",
pages = "95--100",
journal = "European Journal of Pediatric Surgery",
issn = "0939-7248",
publisher = "Thieme Medical Publishers",
number = "2",

}

TY - JOUR

T1 - Severe Congenital Diaphragmatic Hernia (CDH)

T2 - A critical analysis of eight years' experience

AU - Bagolan, Pietro

AU - Casaccia, G.

AU - Nahom, A.

AU - Trucchi, A.

AU - Zangari, A.

AU - Laviani, R.

AU - Pirozzi, N.

AU - Di Liso, G.

AU - Orzalesi, M.

PY - 2002

Y1 - 2002

N2 - Objectives: 1) To define the best outcome of severe Congenital Diaphragmatic Hernia (CDH); 2) to critically evaluate deaths in order to identify possible criteria of exclusion from ECMO; and 3) to identify CDHs which could benefit from ECMO. Materials and Methods: 63 severe CDHs, 35 (55.6%) survivors and 28 (44.4%) nonsurvivors, subdivided into 2 groups according to age at death: Group I dying at 12 ≤ 24 hours, and Group II dying at > 24 hours after birth. The three groups were compared on the basis of prenatal diagnosis, polyhydramnios, gestational age, birth weight, pneumothorax, best values of postductal PaCO2 and PaO2, clinical and echocardiographic signs of persistent pulmonary hypertension, and severity of pulmonary hypoplasia (i.e., body weight to bilateral lung weight ratio at autopsy). Results: PaCO2, PaO2 and degree of pulmonary hypoplasia were significantly worse in Group I compared to Group II and to survivors. PaCO2 and PaO2 in Group II did not differ significantly from those of survivors. Conclusions: In severe CDH it is possible: 1) to achieve a survival rate of 56% without ECMO; 2) to identify a group of patients (Group 1 = 27%) with severe pulmonary hypoplasia who would probably die even with ECMO; and 3) to identify a group of patients (Group II = 17%) who might benefit from ECMO treatment.

AB - Objectives: 1) To define the best outcome of severe Congenital Diaphragmatic Hernia (CDH); 2) to critically evaluate deaths in order to identify possible criteria of exclusion from ECMO; and 3) to identify CDHs which could benefit from ECMO. Materials and Methods: 63 severe CDHs, 35 (55.6%) survivors and 28 (44.4%) nonsurvivors, subdivided into 2 groups according to age at death: Group I dying at 12 ≤ 24 hours, and Group II dying at > 24 hours after birth. The three groups were compared on the basis of prenatal diagnosis, polyhydramnios, gestational age, birth weight, pneumothorax, best values of postductal PaCO2 and PaO2, clinical and echocardiographic signs of persistent pulmonary hypertension, and severity of pulmonary hypoplasia (i.e., body weight to bilateral lung weight ratio at autopsy). Results: PaCO2, PaO2 and degree of pulmonary hypoplasia were significantly worse in Group I compared to Group II and to survivors. PaCO2 and PaO2 in Group II did not differ significantly from those of survivors. Conclusions: In severe CDH it is possible: 1) to achieve a survival rate of 56% without ECMO; 2) to identify a group of patients (Group 1 = 27%) with severe pulmonary hypoplasia who would probably die even with ECMO; and 3) to identify a group of patients (Group II = 17%) who might benefit from ECMO treatment.

KW - Congenital diaphragmatic hernia

KW - ECMO

KW - Pulmonary hypoplasia prediction

UR - http://www.scopus.com/inward/record.url?scp=0036104747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036104747&partnerID=8YFLogxK

U2 - 10.1055/s-2002-30159

DO - 10.1055/s-2002-30159

M3 - Article

VL - 12

SP - 95

EP - 100

JO - European Journal of Pediatric Surgery

JF - European Journal of Pediatric Surgery

SN - 0939-7248

IS - 2

ER -